...
首页> 外文期刊>European review for medical and pharmacological sciences. >Efficacy of statin therapy in patients with acute respiratory distress syndrome/acute lung injury: a systematic review and meta-analysis
【24h】

Efficacy of statin therapy in patients with acute respiratory distress syndrome/acute lung injury: a systematic review and meta-analysis

机译:他汀类药物治疗急性呼吸窘迫综合征/急性肺损伤的疗效:系统评价和荟萃分析

获取原文
           

摘要

OBJECTIVE: Approximately 7.5% of patients admitted to Intensive Care Unit (ICU) of hospitals are likely diagnosed with acute lung injury (ALI) or acute respiratory distress syndrome (ALI/ARDS), and more than one-third of the affected patients die with this disease. Despite the improvement in patient care with the availability of mechanical ventilators, mortality among these patients is unabated. Even though many drugs proved effective in preclinical studies, none is efficacious clinically, and no pharmacological treatment is insight. Statins were reported to exert anti-inflammatory effects and it was suggested that these drugs may be useful in ALI/ARDS patients. However, the initial positive results with statins were not confirmed in later studies, raising doubts about their usefulness. In the present meta-analysis, we examined the efficacy of statins in ALI/ARDS patients. MATERIALS AND METHODS: Various databases were searched to identify both randomized clinical trials and cohort studies, where statin users were compared to non-statin users. To increase the strength of the analysis, cohort studies and random clinical trials were combined in the present analysis. RevMan software from the Cochrane Collaboration was used to a conduct meta-analysis. RESULTS: Baseline characteristics indicated that APACHE-III score to be lower in statin users, suggesting some beneficial effects. However, mortality and severe sepsis were unchanged following statin treatment. But results also showed reduced SOFA score and increased number of ventilator-free days among statin users, indicating that statins are likely to have some beneficial effects. CONCLUSIONS: Statin treatment of ALI/ARDS patients seems to improve health in terms of organ failure and also by lowering the need for ventilation. However, the sample size is too small to accurately assess the effects on mortality and sepsis and further investigations are needed.
机译:目的:医院重症监护病房(ICU)约有7.5%的患者很可能被诊断出患有急性肺损伤(ALI)或急性呼吸窘迫综合征(ALI / ARDS),并且超过三分之一的患者死于这种病。尽管使用机械呼吸机改善了患者护理水平,但这些患者的死亡率并未降低。即使许多药物在临床前研究中被证明是有效的,但在临床上没有一种是有效的,并且没有药物治疗是有见地的。据报道他汀类药物具有抗炎作用,并提示这些药物可能对ALI / ARDS患者有用。但是,他汀类药物最初的阳性结果在以后的研究中并未得到证实,这使人们怀疑它们的有效性。在本荟萃分析中,我们检查了他汀类药物在ALI / ARDS患者中的疗效。材料和方法:搜索各种数据库以识别随机临床试验和队列研究,其中将他汀类药物使用者与非他汀类药物使用者进行了比较。为了提高分析的强度,本研究将队列研究和随机临床试验相结合。来自Cochrane Collaboration的RevMan软件用于进行行为荟萃分析。结果:基线特征表明,他汀类药物使用者的APACHE-III评分较低,表明有些有益作用。但是,他汀类药物治疗后的死亡率和严重败血症没有改变。但是结果还显示,他汀类药物使用者的SOFA评分降低,无呼吸机天数增加,这表明他汀类药物可能具有某些有益作用。结论:他汀类药物治疗ALI / ARDS患者似乎可以改善器官衰竭的健康状况,并可以降低通气量。但是,样本量太小,无法准确评估其对死亡率和败血症的影响,需要进一步研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号